IP Library Granted Patent US 8,513,309
Granted Patent B2
US 8,513,309 · App. 13/250,682 · Granted Aug 20, 2013

Perfluorocarbons for use in treating pruritus

Inventor: Gerald Klein (Morrisville, NC)
Assignee: Oxygen Biotherapeutics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,513,309
App. No.
13/250,682
Granted
Aug 20, 2013
Kind
B2
Abstract

The subject application provides a method of treating pruritus comprising administering to the skin of a subject afflicted with pruritus an amount of a perfluorocarbon effective to treat the pruritus. The subject application also provides a method of alleviating a symptom of psoriasis comprising administering to the skin of a subject afflicted with psoriasis an amount of a perfluorocarbon effective to alleviate the symptom of psoriasis. The subject application also provides a perfluorocarbon composition for use in treating a subject afflicted with pruritus or psoriasis. The subject application further provides a pharmaceutical composition comprising an amount of a perfluorocarbon for use in treating pruritus or psoriasis.

Claims (20)

1. A method of treating pruritus comprising administering to the skin of a subject afflicted with pruritus an amount of a perfluorocarbon effective to treat the pruritus.

2. The method of claim 1 , wherein the pruritus is induced by histamine, a burn, an infection or hemodialysis.

3. The method of claim 1 , wherein the pruritus is a symptom of an inflammatory skin condition, xerosis, an insect bite, a dermatological allergic response, allergic dermatitis, allergic contact dermatitis, photodermatitis, hand dermatitis, miliaria rubra, eczema, atopic dermatitis or contact dermatitis.

4. The method of claim 3 , wherein the inflammatory skin condition is psoriasis or allergic vulvovaginitis.

5. The method of claim 1 , wherein the pruritus is anal pruritus, uremic pruritus or aquagenic pruritus.

6. A method of alleviating a symptom of psoriasis comprising administering to the skin of a subject afflicted with psoriasis an amount of a perfluorocarbon effective to alleviate the symptom of psoriasis.

7. The method of claim 6 , wherein the symptom is pruritus.

8. The method of claim 1 , wherein the molecular formula of the perfluorocarbon consists 9-12 carbon atoms.

9. The method of claim 1 , wherein the perfluorocarbon is perfluoro(tert-butylcyclohexane) perfluoro-n-butylcyclohexane, perfluorodecalin, trimethyl perfluorodecalin, perfluoroisopropyldecalin, perfluoro-tripropylamine, perfluorotributylamine, perfluoro-methylcyclohexylpiperidine, perfluoro-octylbromide, perfluoro-decylbromide, perfluoro-dichlorooctane, perfluorohexane, dodecafluoropentane, or a mixture thereof.

10. The method of claim 9 , wherein the perfluorocarbon is perfluoro(tert-butylcyclohexane) or perfluoro-n-butylcyclohexane.

11. The method of claim 1 , wherein the perfluorocarbon is in a perfluorocarbon gel or emulsion.

12. The method of claim 1 , wherein the subject is afflicted with edema, erythema or erythematous lesion.

13. The method of claim 1 , wherein the administration of the perfluorocarbon reduces subject-perceived itching.

14. The method of claim 1 , wherein the administration of the perfluorocarbon relieves the subject's pruritus for 3 hours or more.

15. The method of claim 1 , wherein the administration of the perfluorocarbon relieves the subject's pruritus within 1 minute of the administration.

16. The method of claim 1 , wherein the subject is human.

17. The method of claim 6 , wherein the perfluorocarbon is perfluoro(tert-butylcyclohexane) or perfluoro-n-butylcyclohexane.

18. The method of claim 6 , wherein the perfluorocarbon is in a perfluorocarbon gel or emulsion.

19. The method of claim 7 , wherein the administration of the perfluorocarbon relieves the subject's pruritus for 3 hours or more.

20. The method of claim 7 , wherein the administration of the perfluorocarbon relieves the subject's pruritus within 1 minute of the administration.

Assignments (2)
CHANGE OF NAME Recorded Oct 30, 2014
From: OXYGEN BIOTHERAPEUTICS, INC.
To: TENAX THERAPEUTICS, INC
Reel/Frame 034112/0946 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2011
From: KLEIN, GERALD
To: OXYGEN BIOTHERAPEUTICS, INC.
Reel/Frame 027201/0620 →
Continuity (3)
Provisional Application 61389089 · Oct 1, 2010
Provisional Application 61393687 · Oct 15, 2010
Related Publication 20120083510A1 · Apr 5, 2012